Aug 2018
A study conducted by researchers from The Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney found that almost two thirds of 640 Australian GPs surveyed have had patients ask about the drug. However, most of GPs who took part in the survey didn’t feel they knew enough about medicinal cannabis to discuss it with their patients and fewer than one in 10 knew the process involved in prescribing medicinal cannabis. Read the article here.
One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
What’s most important in business – purpose or profit? At ANTG we get to achieve both.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >